Fonte: Vaccines. Unidades: ICB, FM
Assuntos: PARASITOLOGIA, MICROBIOLOGIA, PROTEÍNAS RECOMBINANTES, PROTEÍNAS SANGUÍNEAS, ANTICORPOS, IMUNOGENICIDADE DA VACINA, IMUNOGENÉTICA, IMUNOGLOBULINAS, COVID-19, VACINAS VIRAIS
ABNT
SILVA, Mariângela de Oliveira et al. Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein. Vaccines, v. 12, n. 4, p. 14 , 2024Tradução . . Disponível em: https://doi.org/10.3390/vaccines12040356. Acesso em: 17 nov. 2024.APA
Silva, M. de O., Castro-Amarante, M. F., Carvalho, A. A. V. B., Almeida, B. da S., Daher, I. P., Souza-Silva, G. A. de, et al. (2024). Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein. Vaccines, 12( 4), 14 . doi:10.3390/vaccines12040356NLM
Silva M de O, Castro-Amarante MF, Carvalho AAVB, Almeida B da S, Daher IP, Souza-Silva GA de, Yamamoto MM, Koike G, Souza EE de, Wrenger C, Ferreira LC de S, Boscardin SB. Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein [Internet]. Vaccines. 2024 ; 12( 4): 14 .[citado 2024 nov. 17 ] Available from: https://doi.org/10.3390/vaccines12040356Vancouver
Silva M de O, Castro-Amarante MF, Carvalho AAVB, Almeida B da S, Daher IP, Souza-Silva GA de, Yamamoto MM, Koike G, Souza EE de, Wrenger C, Ferreira LC de S, Boscardin SB. Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein [Internet]. Vaccines. 2024 ; 12( 4): 14 .[citado 2024 nov. 17 ] Available from: https://doi.org/10.3390/vaccines12040356